Zacks Investment Research downgraded shares of Select Medical (NYSE:SEM) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning.

According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “

Separately, ValuEngine lowered Select Medical from a strong-buy rating to a buy rating in a research note on Monday, May 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. The stock has an average rating of Buy and a consensus target price of $20.71.

Shares of SEM traded down $0.20 during mid-day trading on Tuesday, hitting $19.40. The stock had a trading volume of 5,454 shares, compared to its average volume of 623,483. The firm has a market cap of $2.73 billion, a PE ratio of 20.21, a PEG ratio of 1.38 and a beta of 1.37. The company has a debt-to-equity ratio of 3.35, a current ratio of 1.62 and a quick ratio of 1.62. Select Medical has a 52 week low of $15.85 and a 52 week high of $21.65.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, August 2nd. The health services provider reported $0.31 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.36 by ($0.05). The firm had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.29 billion. Select Medical had a net margin of 4.17% and a return on equity of 16.90%. The business’s quarterly revenue was up 15.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.32 earnings per share. sell-side analysts anticipate that Select Medical will post 1.02 earnings per share for the current fiscal year.

In other news, insider David S. Chernow sold 41,202 shares of Select Medical stock in a transaction on Tuesday, August 7th. The stock was sold at an average price of $19.81, for a total value of $816,211.62. Following the completion of the transaction, the insider now directly owns 891,455 shares in the company, valued at $17,659,723.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Robert A. Ortenzio sold 100,276 shares of Select Medical stock in a transaction on Friday, May 18th. The shares were sold at an average price of $18.53, for a total value of $1,858,114.28. Following the completion of the transaction, the chairman now owns 7,225,885 shares of the company’s stock, valued at $133,895,649.05. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 729,014 shares of company stock worth $13,682,385. Corporate insiders own 19.86% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in SEM. Victory Capital Management Inc. grew its position in shares of Select Medical by 39.0% in the first quarter. Victory Capital Management Inc. now owns 1,740,986 shares of the health services provider’s stock valued at $30,032,000 after purchasing an additional 488,636 shares in the last quarter. Matarin Capital Management LLC purchased a new position in shares of Select Medical in the first quarter valued at $4,118,000. BlackRock Inc. grew its position in shares of Select Medical by 1.4% in the first quarter. BlackRock Inc. now owns 14,032,703 shares of the health services provider’s stock valued at $242,062,000 after purchasing an additional 196,009 shares in the last quarter. Millennium Management LLC grew its position in shares of Select Medical by 17.4% in the first quarter. Millennium Management LLC now owns 1,292,387 shares of the health services provider’s stock valued at $22,294,000 after purchasing an additional 191,715 shares in the last quarter. Finally, Deutsche Bank AG grew its position in shares of Select Medical by 110.0% in the fourth quarter. Deutsche Bank AG now owns 320,618 shares of the health services provider’s stock valued at $5,657,000 after purchasing an additional 167,962 shares in the last quarter. Institutional investors own 75.16% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

Featured Story: Leveraged Buyout (LBO) Explained

Get a free copy of the Zacks research report on Select Medical (SEM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.